Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
142

Summary

Conditions
Relapsing Remitting Multiple Sclerosis
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 10 years and 17 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02283853
Collaborators
Not Provided
Investigators
Study Director: Medical Director Biogen